US20120078159A1 - Multi-lumen ventricular drainage catheter - Google Patents

Multi-lumen ventricular drainage catheter Download PDF

Info

Publication number
US20120078159A1
US20120078159A1 US12/894,111 US89411110A US2012078159A1 US 20120078159 A1 US20120078159 A1 US 20120078159A1 US 89411110 A US89411110 A US 89411110A US 2012078159 A1 US2012078159 A1 US 2012078159A1
Authority
US
United States
Prior art keywords
catheter
aperture
distal end
enlarged opening
lumens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/894,111
Inventor
Stephen F. Wilson
Emilie Neukom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Spine LLC
DePuy Synthes Products Inc
Original Assignee
Codman and Shurtleff Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US12/894,111 priority Critical patent/US20120078159A1/en
Application filed by Codman and Shurtleff Inc filed Critical Codman and Shurtleff Inc
Assigned to CODMAN & SHURTLEFF, INC. reassignment CODMAN & SHURTLEFF, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Neukom, Emilie, WILSON, STEPHEN
Priority to CA2749653A priority patent/CA2749653C/en
Priority to CO11119195A priority patent/CO6640044A1/en
Priority to AU2011226839A priority patent/AU2011226839A1/en
Priority to JP2011212506A priority patent/JP2012071135A/en
Priority to EP11183166.5A priority patent/EP2436419B1/en
Publication of US20120078159A1 publication Critical patent/US20120078159A1/en
Assigned to DEPUY SPINE, INC. reassignment DEPUY SPINE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CODMAN & SHURTLEFF, INC.
Assigned to HAND INNOVATIONS LLC reassignment HAND INNOVATIONS LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DEPUY SPINE, LLC
Assigned to DePuy Synthes Products, LLC reassignment DePuy Synthes Products, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: HAND INNOVATIONS LLC
Priority to US14/182,997 priority patent/US10232151B2/en
Assigned to DEPUY SPINE, LLC reassignment DEPUY SPINE, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 030341 FRAME: 0689. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Assignors: CODMAN & SHURTLEFF, INC.
Priority to AU2016204328A priority patent/AU2016204328B2/en
Assigned to DePuy Synthes Products, Inc. reassignment DePuy Synthes Products, Inc. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DePuy Synthes Products, LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/006Cerebrospinal drainage; Accessories therefor, e.g. valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/0071Multiple separate lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/04General characteristics of the apparatus implanted
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0693Brain, cerebrum

Definitions

  • the present invention relates generally to a shunt and a catheter having a system for reducing the risk of blockage or obstruction of the catheter apertures and also increases the ease of revision surgery if the catheter is removed.
  • Hydrocephalus is a neurological condition that is caused by the abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles, or cavities, of the brain.
  • CSF cerebrospinal fluid
  • CSF is a clear, colorless fluid that is primarily produced by the choroid plexus and surrounds the brain and spinal cord.
  • CSF constantly circulates through the ventricular system of the brain and is ultimately absorbed into the bloodstream.
  • CSF aids in the protection of the brain and spinal cord. Because CSF keeps the brain and spinal cord buoyant, it acts as a protective cushion or “shock absorber” to prevent injuries to the central nervous system.
  • Hydrocephalus which affects children and adults, arises when the normal drainage of CSF in the brain is blocked in some way.
  • Such blockage can be caused by a number of factors, including, for example, genetic predisposition, intraventricular or intracranial hemorrhage, infections such as meningitis, head trauma, or the like. Blockage of the flow of CSF consequently creates an imbalance between the amount of CSF produced by the choroid plexus and the rate at which CSF is absorbed into the bloodstream, thereby increasing pressure on the brain, which causes the ventricles to enlarge.
  • Hydrocephalus is most often treated by surgically inserting a shunt system that diverts the flow of CSF from the ventricle to another area of the body where the CSF can be absorbed as part of the circulatory system.
  • Shunt systems come in a variety of models, and typically share similar functional components. These components include a ventricular catheter which is introduced through a burr hole in the skull and implanted in the patient's ventricle, a drainage catheter that carries the CSF to its ultimate drainage site, and optionally a flow-control mechanism, e.g., shunt valve, that regulates the one-way flow of CSF from the ventricle to the drainage site to maintain normal pressure within the ventricles.
  • the ventricular catheter typically contains multiple holes or apertures positioned along the length of the ventricular catheter to allow the CSF to enter into the shunt system, as shown in FIGS. 6 and 7 .
  • Shunting is considered one of the basic neurosurgical procedures, yet it has the highest complication rate.
  • the most common complication with shunting is obstruction of the system. Although obstruction or clogging may occur at any point along the shunt system, it most frequently occurs at the ventricular end of the shunt system. While there are several ways that the ventricular catheter may become blocked or clogged, obstruction is typically caused by growth of tissue, such as the choroid plexus, around the catheter and into the apertures, as shown in FIG. 7 .
  • the apertures of the ventricular catheter can also be obstructed by debris, bacteria, or coagulated blood.
  • backflushing is a process that uses the CSF present in the shunt system to remove the obstructing matter. This process can be ineffective, however, due to the small size of the apertures of the ventricular catheter and due to the small amount of flushing liquid available in the shunt system.
  • Other shunt systems have been designed to include a mechanism for flushing the shunt system.
  • some shunt systems include a pumping device within the system which causes fluid in the system to flow with considerable pressure and velocity, thereby flushing the system.
  • using a built-in mechanism to flush the shunt system can also fail to remove the obstruction due to factors such as the size of the apertures and the degree and extent to which the apertures have been clogged.
  • Occluded ventricular catheters can also be repaired by cauterizing the catheter to remove blocking tissue, thereby reopening existing apertures that have become occluded.
  • new apertures can be created in the catheter. These repairs, however, may be incapable of removing obstructions from the ventricular catheter depending on the location of the clogged apertures.
  • the extent of tissue growth into and around the catheter can also preclude the creation of additional apertures, for example, in situations where the tissue growth covers a substantial portion of the ventricular catheter.
  • Another disadvantage of creating new apertures to repair an occluded ventricular catheter is that this method fails to prevent or reduce the risk of repeated obstructions.
  • occlusion is more often treated by replacing the catheter. Although this can be accomplished by removing the obstructed catheter from the ventricle, the growth of the choroid plexus and other tissues around the catheter and into the apertures can hinder removal and replacement of the catheter. Care must be exercised to avoid damage to the choroid plexus, which can cause severe injury to the patient, such as, for example, hemorrhaging. Not only do these procedures pose a significant risk of injury to the patient, they can also be very costly, especially when shunt obstruction is a recurring problem.
  • the present invention provides a shunt that includes a housing having an inlet, an outlet and a flow control mechanism disposed within the housing.
  • a ventricular catheter is connected to the inlet of the housing.
  • the catheter has a longitudinal length, a proximal end, a distal end, and an inner lumen extending therethrough.
  • the inner lumen of the catheter includes at least two lumens at the distal end and has only one lumen at the proximal end.
  • the catheter has one aperture corresponding to each of the at least two lumens located at the distal end of the catheter.
  • FIG. 1 is a top perspective view of the shunt and ventricular catheter according to the present invention
  • FIG. 2 is a partial perspective view, with parts broken away, showing the interior of the ventricular catheter according to the present invention
  • FIG. 3 is a cross-sectional view taken along lines 3 - 3 of FIG. 2 and looking in the direction of the arrows;
  • FIG. 4 is a cross-sectional view taken along lines 4 - 4 of FIG. 3 and looking in the direction of the arrows;
  • FIG. 4A is a cross-sectional view taken along lines 4 A- 4 A of FIG. 3 and looking in the direction of the arrows;
  • FIG. 5 is a cross-sectional view taken along lines 5 - 5 of FIG. 3 and looking in the direction of the arrows;
  • FIG. 6 is a partial top view of a prior art ventricular catheter
  • FIG. 7 is cross-sectional view taken along lines 7 - 7 of FIG. 6 and looking in the direction of the arrows;
  • FIG. 8A is a partial top view of the ventricular catheter according to the present invention.
  • FIG. 8B is a partial top view of the ventricular catheter according to the present invention.
  • FIGS. 1-5 , 8 A, 8 B and 9 a shunt 10 and a ventricular catheter 12 in accordance with the present invention is illustrated.
  • shunt 10 has a housing 14 , which has an inlet 16 , an outlet 18 and a flow control mechanism disposed therein.
  • Ventricular catheter 12 is connected to inlet 16 of the housing.
  • Catheter 12 has a longitudinal length, a proximal end 20 , a distal end 22 , and an inner lumen 24 extending therethrough.
  • Inner lumen 24 is a single lumen at proximal end 20 of the catheter and is comprised of two or more lumens 24 1 , 24 11 , 24 111 , 24 1111 , etc. at the distal end 22 of catheter 12 .
  • Catheter 12 is preferably made of silicone.
  • catheter 12 can be impregnated with antimicrobial antibiotics, such as the CODMAN® BACTISEAL® catheter, which is commercially sold by Codman & Shurtleff, Inc. of Raynham, Mass.
  • Ventricular catheter 12 has only one aperture 26 at distal end 22 of catheter 12 corresponding to each of the lumens 24 1 , 24 111 , 24 1111 , etc. There are preferably between 2 and 7lumens, with only three and four lumens being shown in the drawing Figures for the sake of brevity. Of course, one skilled in the art would readily know how to make the ventricular catheter of the present invention with multiple lumens based on the present disclosure.
  • Each tapering slit 30 receives cerebrospinal fluid (CSF) when in use.
  • Each aperture 26 has an enlarged opening 28 at the distal end and transitions from the enlarged opening to a tapering slit 30 at the proximal end of the aperture.
  • a portion 32 between the enlarged opening 28 and the tapering slit 30 is a slit 32 of constant thickness.
  • a slit 42 of constant thickness can be disposed between the enlarged opening 28 and the proximal end of the aperture with no tapering slit being utilized.
  • the entire aperture, from the enlarged opening 28 to the proximal end of tapering slit 30 is in fluid communication with its respective lumen 24 1 , 24 111 , 24 1111 , etc.
  • the enlarged opening 28 of each aperture has a smooth concave inner surface 34 , similar to a spoon shape.
  • multiple lumens 24 1 , 24 111 , 24 1111 , etc. in accordance with the present invention help prevent complete occlusion of ventricular catheter 12 .
  • ventricular catheter 12 can only be completely occluded if all the lumens become blocked.
  • any ingrowth of choroid plexus or ependymal tissue must extend beyond this junction to cause complete occlusion and interconnection of tissue from multiple apertures, which is unlikely to happen because of the length the tissue has to grow.
  • the only other way that the choroid plexus or ependymal tissue would cause a complete occlusion is for the tissue to block each of the multiple lumens 24 beyond the slit 30 , or to occlude the entire slit 30 and the aperture 26 .
  • the slit lumen geometry is preferably tapered or purposely shaped to provide resistance to fluid flow through the slit that corresponds to the size of the pathway provided by the slit.
  • the size of the slit opening distributes the pressure gradient over a larger distance and surface area than conventional ventricular catheters. Diffusing the pressure gradient diminishes the attractive fluid forces and diminishes areas of high fluid flow, thereby lessens the propensity for tissue ingrowth.
  • tissue ingrowth 36 is illustrated. As can be seen, tissue ingrowth into aperture 26 will not interconnect with tissue ingrowth from another lumen. Thus, should the ventricular catheter 12 need to be removed, catheter 12 will be pulled back out and tissue ingrowth 36 can be removed from the lumen at the wider end of the taper or at the enlarged opening 28 , as illustrated in FIG. 8B . In contrast, in the prior art, tissue ingrowth 36 can be rather difficult to remover from the ventricular catheter should the ventricular catheter 12 need to be removed, as discussed above.
  • ventricular catheter 12 has a blunt distal end 38 to permit the catheter to be introduced into the brain without damaging brain tissue.
  • an inner concave surface 40 is sized to receive a stylet for use in introducing the catheter.

Abstract

A shunt includes a housing having an inlet, an outlet and a flow control mechanism disposed within the housing. A ventricular catheter is connected to the inlet of the housing. The catheter has a longitudinal length, a proximal end, a distal end, and an inner lumen extending therethrough. The inner lumen of the catheter includes at least two lumens at the distal end and has only one lumen at the proximal end. The catheter has one slit and aperture corresponding to each of the at least two lumens located at the distal end of the catheter.

Description

    FIELD OF THE INVENTION
  • The present invention relates generally to a shunt and a catheter having a system for reducing the risk of blockage or obstruction of the catheter apertures and also increases the ease of revision surgery if the catheter is removed.
  • BACKGROUND OF THE INVENTION
  • Hydrocephalus is a neurological condition that is caused by the abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles, or cavities, of the brain. CSF is a clear, colorless fluid that is primarily produced by the choroid plexus and surrounds the brain and spinal cord. CSF constantly circulates through the ventricular system of the brain and is ultimately absorbed into the bloodstream. CSF aids in the protection of the brain and spinal cord. Because CSF keeps the brain and spinal cord buoyant, it acts as a protective cushion or “shock absorber” to prevent injuries to the central nervous system.
  • Hydrocephalus, which affects children and adults, arises when the normal drainage of CSF in the brain is blocked in some way. Such blockage can be caused by a number of factors, including, for example, genetic predisposition, intraventricular or intracranial hemorrhage, infections such as meningitis, head trauma, or the like. Blockage of the flow of CSF consequently creates an imbalance between the amount of CSF produced by the choroid plexus and the rate at which CSF is absorbed into the bloodstream, thereby increasing pressure on the brain, which causes the ventricles to enlarge.
  • Hydrocephalus is most often treated by surgically inserting a shunt system that diverts the flow of CSF from the ventricle to another area of the body where the CSF can be absorbed as part of the circulatory system. Shunt systems come in a variety of models, and typically share similar functional components. These components include a ventricular catheter which is introduced through a burr hole in the skull and implanted in the patient's ventricle, a drainage catheter that carries the CSF to its ultimate drainage site, and optionally a flow-control mechanism, e.g., shunt valve, that regulates the one-way flow of CSF from the ventricle to the drainage site to maintain normal pressure within the ventricles. The ventricular catheter typically contains multiple holes or apertures positioned along the length of the ventricular catheter to allow the CSF to enter into the shunt system, as shown in FIGS. 6 and 7.
  • Shunting is considered one of the basic neurosurgical procedures, yet it has the highest complication rate. The most common complication with shunting is obstruction of the system. Although obstruction or clogging may occur at any point along the shunt system, it most frequently occurs at the ventricular end of the shunt system. While there are several ways that the ventricular catheter may become blocked or clogged, obstruction is typically caused by growth of tissue, such as the choroid plexus, around the catheter and into the apertures, as shown in FIG. 7. The apertures of the ventricular catheter can also be obstructed by debris, bacteria, or coagulated blood.
  • Some of these problems can be treated by backflushing, which is a process that uses the CSF present in the shunt system to remove the obstructing matter. This process can be ineffective, however, due to the small size of the apertures of the ventricular catheter and due to the small amount of flushing liquid available in the shunt system. Other shunt systems have been designed to include a mechanism for flushing the shunt system. For example, some shunt systems include a pumping device within the system which causes fluid in the system to flow with considerable pressure and velocity, thereby flushing the system. As with the process of backflushing, using a built-in mechanism to flush the shunt system can also fail to remove the obstruction due to factors such as the size of the apertures and the degree and extent to which the apertures have been clogged.
  • Occluded ventricular catheters can also be repaired by cauterizing the catheter to remove blocking tissue, thereby reopening existing apertures that have become occluded. Alternatively, new apertures can be created in the catheter. These repairs, however, may be incapable of removing obstructions from the ventricular catheter depending on the location of the clogged apertures. Additionally, the extent of tissue growth into and around the catheter can also preclude the creation of additional apertures, for example, in situations where the tissue growth covers a substantial portion of the ventricular catheter. Another disadvantage of creating new apertures to repair an occluded ventricular catheter is that this method fails to prevent or reduce the risk of repeated obstructions.
  • Because attempts at flushing or repairing a blocked ventricular catheter are often futile and ineffective, occlusion is more often treated by replacing the catheter. Although this can be accomplished by removing the obstructed catheter from the ventricle, the growth of the choroid plexus and other tissues around the catheter and into the apertures can hinder removal and replacement of the catheter. Care must be exercised to avoid damage to the choroid plexus, which can cause severe injury to the patient, such as, for example, hemorrhaging. Not only do these procedures pose a significant risk of injury to the patient, they can also be very costly, especially when shunt obstruction is a recurring problem.
  • Accordingly, there exists a need for a shunt and a ventricular catheter that minimizes or eliminates the risk of blockage or obstruction of the catheter apertures, that increases the ease of revision surgery if the catheter is removed and reduces the need for repeated repair and/or replacement.
  • SUMMARY OF THE INVENTION
  • The present invention provides a shunt that includes a housing having an inlet, an outlet and a flow control mechanism disposed within the housing. A ventricular catheter is connected to the inlet of the housing. The catheter has a longitudinal length, a proximal end, a distal end, and an inner lumen extending therethrough. The inner lumen of the catheter includes at least two lumens at the distal end and has only one lumen at the proximal end. The catheter has one aperture corresponding to each of the at least two lumens located at the distal end of the catheter.
  • BRIEF DESCRIPTION OF THE DRAWING FIGURES
  • FIG. 1 is a top perspective view of the shunt and ventricular catheter according to the present invention;
  • FIG. 2 is a partial perspective view, with parts broken away, showing the interior of the ventricular catheter according to the present invention;
  • FIG. 3 is a cross-sectional view taken along lines 3-3 of FIG. 2 and looking in the direction of the arrows;
  • FIG. 4 is a cross-sectional view taken along lines 4-4 of FIG. 3 and looking in the direction of the arrows;
  • FIG. 4A is a cross-sectional view taken along lines 4A-4A of FIG. 3 and looking in the direction of the arrows;
  • FIG. 5 is a cross-sectional view taken along lines 5-5 of FIG. 3 and looking in the direction of the arrows;
  • FIG. 6 is a partial top view of a prior art ventricular catheter;
  • FIG. 7 is cross-sectional view taken along lines 7-7 of FIG. 6 and looking in the direction of the arrows;
  • FIG. 8A is a partial top view of the ventricular catheter according to the present invention; and
  • FIG. 8B is a partial top view of the ventricular catheter according to the present invention.
  • DETAILED DESCRIPTION OF THE PRESENT INVENTION
  • Referring now to FIGS. 1-5, 8A, 8B and 9 a shunt 10 and a ventricular catheter 12 in accordance with the present invention is illustrated.
  • As illustrated in FIG. 1, shunt 10 has a housing 14, which has an inlet 16, an outlet 18 and a flow control mechanism disposed therein. Ventricular catheter 12 is connected to inlet 16 of the housing. Catheter 12 has a longitudinal length, a proximal end 20, a distal end 22, and an inner lumen 24 extending therethrough. Inner lumen 24 is a single lumen at proximal end 20 of the catheter and is comprised of two or more lumens 24 1, 24 11, 24 111, 24 1111, etc. at the distal end 22 of catheter 12. Catheter 12 is preferably made of silicone. In addition, catheter 12 can be impregnated with antimicrobial antibiotics, such as the CODMAN® BACTISEAL® catheter, which is commercially sold by Codman & Shurtleff, Inc. of Raynham, Mass.
  • Ventricular catheter 12 has only one aperture 26 at distal end 22 of catheter 12 corresponding to each of the lumens 24 1, 24 111, 24 1111, etc. There are preferably between 2 and 7lumens, with only three and four lumens being shown in the drawing Figures for the sake of brevity. Of course, one skilled in the art would readily know how to make the ventricular catheter of the present invention with multiple lumens based on the present disclosure. Each tapering slit 30 receives cerebrospinal fluid (CSF) when in use. Each aperture 26 has an enlarged opening 28 at the distal end and transitions from the enlarged opening to a tapering slit 30 at the proximal end of the aperture. In some examples of the present invention, for each aperture 26, a portion 32 between the enlarged opening 28 and the tapering slit 30 is a slit 32 of constant thickness. Likewise, in other examples of the present invention, for each aperture 26, there may be no portion 32 between the enlarged opening 28 and the tapering slit 30. In addition, as illustrated in FIG. 9, for each aperture 26, a slit 42 of constant thickness can be disposed between the enlarged opening 28 and the proximal end of the aperture with no tapering slit being utilized. The entire aperture, from the enlarged opening 28 to the proximal end of tapering slit 30 is in fluid communication with its respective lumen 24 1, 24 111, 24 1111, etc. The enlarged opening 28 of each aperture has a smooth concave inner surface 34, similar to a spoon shape.
  • The use of multiple lumens 24 1, 24 111, 24 1111, etc. in accordance with the present invention help prevent complete occlusion of ventricular catheter 12. In the present invention, ventricular catheter 12 can only be completely occluded if all the lumens become blocked. In addition, because the transition from multiple lumens to a single lumen 24 occurs from about 0.5 to about 3.0 centimeters from the distal end of the ventricular catheter, any ingrowth of choroid plexus or ependymal tissue must extend beyond this junction to cause complete occlusion and interconnection of tissue from multiple apertures, which is unlikely to happen because of the length the tissue has to grow. The only other way that the choroid plexus or ependymal tissue would cause a complete occlusion is for the tissue to block each of the multiple lumens 24 beyond the slit 30, or to occlude the entire slit 30 and the aperture 26.
  • The slit lumen geometry is preferably tapered or purposely shaped to provide resistance to fluid flow through the slit that corresponds to the size of the pathway provided by the slit. The size of the slit opening distributes the pressure gradient over a larger distance and surface area than conventional ventricular catheters. Diffusing the pressure gradient diminishes the attractive fluid forces and diminishes areas of high fluid flow, thereby lessens the propensity for tissue ingrowth.
  • Referring now to FIGS. 8A and 8B of the present invention, tissue ingrowth 36 is illustrated. As can be seen, tissue ingrowth into aperture 26 will not interconnect with tissue ingrowth from another lumen. Thus, should the ventricular catheter 12 need to be removed, catheter 12 will be pulled back out and tissue ingrowth 36 can be removed from the lumen at the wider end of the taper or at the enlarged opening 28, as illustrated in FIG. 8B. In contrast, in the prior art, tissue ingrowth 36 can be rather difficult to remover from the ventricular catheter should the ventricular catheter 12 need to be removed, as discussed above.
  • Referring now to FIGS. 2 and 3, ventricular catheter 12, has a blunt distal end 38 to permit the catheter to be introduced into the brain without damaging brain tissue. In addition, an inner concave surface 40 is sized to receive a stylet for use in introducing the catheter.
  • It will be understood that the foregoing is only illustrative of the principles of the invention, and that various modifications can be made by those skilled in the art without departing from the scope and spirit of the invention. All references cited herein are expressly incorporated by reference in their entirety.

Claims (29)

1. A shunt comprising:
a housing having an inlet, an outlet and a flow control mechanism disposed therein;
a catheter connected to the inlet of the housing, the catheter having a longitudinal length, a proximal end, a distal end, and an inner lumen extending therethrough, the inner lumen of the catheter being comprised of at least two lumens at the distal end and being comprised of only one lumen at the proximal end, the catheter having an aperture adjacent to the distal end corresponding to each of the at least two lumens.
2. The shunt according to claim 1, wherein each aperture has an enlarged opening at the distal end and transitions from the enlarged opening to a tapering slit at the proximal end of the aperture.
3. The shunt according to claim 2, wherein a portion of each aperture between the enlarged opening and the tapering slit is a slit of constant thickness.
4. The shunt according to claim 3, wherein the enlarged opening of each aperture has a smooth concave inner surface.
5. The shunt according to claim 1, wherein the enlarged opening of each aperture has a smooth concave inner surface.
6. The shunt according to claim 1, wherein the inner lumen of the catheter being comprised of at least three lumens at the distal end.
7. The shunt according to claim 6, wherein the inner lumen of the catheter being comprised of at least four lumens at the distal end.
8. The shunt according to claim 1, wherein the catheter has only one aperture adjacent to the distal end corresponding to each of the at least two lumens.
9. A shunt comprising:
a housing having an inlet, an outlet and a flow control mechanism disposed therein;
a catheter connected to the inlet of the housing, the catheter having a longitudinal length, a proximal end, a distal end, and an inner lumen extending therethrough, the inner lumen of the catheter having an aperture that has an enlarged opening at the distal end and transitions from the enlarged opening to a tapering slit at the proximal end of the aperture.
10. The shunt according to claim 9, wherein a portion of each aperture between the enlarged opening and the tapering slit is a slit of constant thickness.
11. The shunt according to claim 9, wherein the enlarged opening of each aperture has a smooth concave inner surface.
12. The shunt according to claim 9, wherein the enlarged opening of each aperture has a smooth concave inner surface.
13. The shunt according to claim 9, wherein the inner lumen of the catheter being comprised of at least three lumens at the distal end.
14. The shunt according to claim 13, wherein the inner lumen of the catheter being comprised of at least four lumens at the distal end.
15. The shunt according to claim 9, wherein catheter has only one aperture adjacent to the distal end thereof
16. The shunt according to claim 9, wherein catheter has at least two apertures adjacent to the distal end thereof
17. A ventricular catheter comprising:
the ventricular catheter having a longitudinal length, a proximal end, a distal end, and an inner lumen extending therethrough, the inner lumen of the catheter being comprised of at least two lumens at the distal end and being comprised of only one lumen at the proximal end, the catheter having only one aperture adjacent to the distal end corresponding to each of the at least two lumens.
18. The ventricular catheter according to claim 17, wherein each aperture has an enlarged opening at the distal end and transitions from the enlarged opening to a tapering slit at the proximal end of the aperture.
19. The ventricular catheter according to claim 18, wherein a portion of each aperture between the enlarged opening and the tapering slit is a slit of constant thickness.
20. The ventricular catheter according to claim 17, wherein the enlarged opening of each aperture has a smooth concave inner surface.
21. The ventricular catheter according to claim 17, wherein the enlarged opening of each aperture has a smooth concave inner surface.
22. The ventricular catheter according to claim 17, wherein the inner lumen of the catheter being comprised of at least three lumens at the distal end.
23. The ventricular catheter according to claim 22, wherein the inner lumen of the catheter being comprised of at least four lumens at the distal end.
24. A ventricular catheter comprising:
the ventricular catheter having a longitudinal length, a proximal end, a distal end, and an inner lumen extending therethrough, the catheter having an aperture that has an enlarged opening at the distal end and transitions from the enlarged opening to a tapering slit at the proximal end of the aperture.
25. The ventricular catheter according to claim 24, wherein a portion of each aperture between the enlarged opening and the tapering slit is a slit of constant thickness.
26. The ventricular catheter according to claim 24, wherein the enlarged opening of each aperture has a smooth concave inner surface.
27. The ventricular catheter according to claim 24, wherein the enlarged opening of each aperture has a smooth concave inner surface.
28. The ventricular catheter according to claim 24, wherein the inner lumen of the catheter being comprised of at least three lumens at the distal end.
29. The ventricular catheter according to claim 29, wherein the inner lumen of the catheter being comprised of at least four lumens at the distal end.
US12/894,111 2010-09-29 2010-09-29 Multi-lumen ventricular drainage catheter Abandoned US20120078159A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US12/894,111 US20120078159A1 (en) 2010-09-29 2010-09-29 Multi-lumen ventricular drainage catheter
CA2749653A CA2749653C (en) 2010-09-29 2011-08-19 Multiple lumen ventricular drainage catheter
CO11119195A CO6640044A1 (en) 2010-09-29 2011-09-14 Multilumen ventricular drainage catheter
AU2011226839A AU2011226839A1 (en) 2010-09-29 2011-09-23 Multi-lumen ventricular drainage catheter
JP2011212506A JP2012071135A (en) 2010-09-29 2011-09-28 Multi-lumen ventricular drainage catheter
EP11183166.5A EP2436419B1 (en) 2010-09-29 2011-09-28 Multiple lumen ventricular drainage catheter
US14/182,997 US10232151B2 (en) 2010-09-29 2014-02-18 Multi-lumen ventricular drainage catheter
AU2016204328A AU2016204328B2 (en) 2010-09-29 2016-06-24 Multi-lumen ventricular drainage catheter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/894,111 US20120078159A1 (en) 2010-09-29 2010-09-29 Multi-lumen ventricular drainage catheter

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/182,997 Continuation US10232151B2 (en) 2010-09-29 2014-02-18 Multi-lumen ventricular drainage catheter

Publications (1)

Publication Number Publication Date
US20120078159A1 true US20120078159A1 (en) 2012-03-29

Family

ID=44785513

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/894,111 Abandoned US20120078159A1 (en) 2010-09-29 2010-09-29 Multi-lumen ventricular drainage catheter
US14/182,997 Active 2033-05-21 US10232151B2 (en) 2010-09-29 2014-02-18 Multi-lumen ventricular drainage catheter

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/182,997 Active 2033-05-21 US10232151B2 (en) 2010-09-29 2014-02-18 Multi-lumen ventricular drainage catheter

Country Status (6)

Country Link
US (2) US20120078159A1 (en)
EP (1) EP2436419B1 (en)
JP (1) JP2012071135A (en)
AU (2) AU2011226839A1 (en)
CA (1) CA2749653C (en)
CO (1) CO6640044A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852156B2 (en) 2012-02-08 2014-10-07 Windrose Medical, Llc. Device for implanting medical catheters
US20160331927A1 (en) * 2014-01-31 2016-11-17 The Regents Of The University Of Colorado, A Body Corporate Ventricular Catheter
WO2019035020A1 (en) 2017-08-18 2019-02-21 Aljazaeri Ayman Hassan A Drainage catheter with retractable internal drains
US10493249B2 (en) 2014-04-18 2019-12-03 Anuncia, Inc. System and methods for shunting fluid
US10518069B2 (en) 2016-10-28 2019-12-31 Integra LifeSciences Switzerland Sarl Implantable valve assembly with extended lifespan
US10639461B2 (en) 2013-01-22 2020-05-05 Anuncia, Inc. Systems and methods for shunting fluid
US10765847B1 (en) 2019-12-10 2020-09-08 Ayman H. Al-Jazaeri Single lumen drainage catheter with extendable and retractable drains
US10792480B2 (en) 2016-10-13 2020-10-06 Anuncia, Inc. Shunt flushers and related methods
WO2023089344A1 (en) * 2021-11-22 2023-05-25 Buckingham Medical Technologies Ltd. Medical cannulas

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2904628C (en) 2013-03-15 2024-02-13 Children's Medical Center Corporation Shunt flusher
CA2987931A1 (en) * 2015-06-01 2016-12-08 University Of Massachusetts Catheter assemblies
US20210338991A1 (en) * 2020-04-29 2021-11-04 Medtronic Xomed, Inc. System and Method for a Covering
WO2022237108A1 (en) * 2021-05-08 2022-11-17 宁波市第一医院 Anti-blocking nephrostomy tube and curved drainage nephrostomy tube

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4465481A (en) * 1981-02-26 1984-08-14 Innovative Surgical Products, Inc. Single piece wound drain catheter
US4795439A (en) * 1986-06-06 1989-01-03 Edward Weck Incorporated Spiral multi-lumen catheter
US4863441A (en) * 1987-07-17 1989-09-05 Minnesota Mining And Manufacturing Company Venous return catheter
US4950232A (en) * 1987-08-11 1990-08-21 Surelab Superior Research Laboratories Cerebrospinal fluid shunt system
US5116310A (en) * 1990-07-30 1992-05-26 Helix Medical, Inc. Multiple lumen wound drain with bypass openings
US5360414A (en) * 1992-10-08 1994-11-01 Yarger Richard J Tube for draining body cavities, viscera and wounds
US5531673A (en) * 1995-05-26 1996-07-02 Helenowski; Tomasz K. Ventricular catheter
US5776096A (en) * 1996-06-06 1998-07-07 Hdc Corporation Dual lumen vascular catheter with expanding side portal
US20030135148A1 (en) * 2002-01-14 2003-07-17 Dextradeur Alan J. Multi-catheter insertion device and method
US6866657B2 (en) * 2002-07-04 2005-03-15 Semyon Shchervinsky Drain catheters
US6893424B2 (en) * 2002-07-04 2005-05-17 Semyon Shchervinsky Drain catheters
US20050251144A1 (en) * 2004-05-04 2005-11-10 Codman & Shurtleff, Inc. Multiple lumen sensor attachment
US7223263B1 (en) * 1999-06-16 2007-05-29 Medi-Tech Co., Ltd. Catheter
US20090118661A1 (en) * 2007-11-01 2009-05-07 C. R. Bard, Inc. Catheter assembly including triple lumen tip
US20090254062A1 (en) * 2008-04-03 2009-10-08 Mcglothlin Mark W Infusion catheters with slit valves and of simplified construction
US7959623B2 (en) * 1999-07-19 2011-06-14 I-Flow Corporation Method of fluid delivery and catheters for use with same

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5345083A (en) 1976-10-05 1978-04-22 Tokyo Ika Shika Daigakuchiyou Silicon double tract for discharging fluid
DE3033459C2 (en) * 1979-03-07 1985-07-18 Gerhard Hug Gmbh, 7801 Umkirch Drainage device
DE2908952C3 (en) 1979-03-07 1981-12-03 Gerhard Hug Gmbh, 7801 Umkirch Drainage device
IT1119233B (en) * 1979-10-17 1986-03-03 Michele Labianca REFERENCES IN CATHETERS FOR CEREBROSPINAL FLUID DERIVATION SYSTEMS FOR HYDROCEPHALY
US4382445A (en) * 1980-12-04 1983-05-10 Cosmos Research Associates Physiological fluid shunt system and improvements therefor
US4398910A (en) 1981-02-26 1983-08-16 Blake L W Wound drain catheter
US4406656A (en) 1981-06-01 1983-09-27 Brack Gillium Hattler Venous catheter having collapsible multi-lumens
US4377169A (en) 1981-06-10 1983-03-22 Banks Bruce A Ion beam sputter-etched ventricular catheter for hydrocephalus shunt
US4610671A (en) 1985-03-28 1986-09-09 Luther Medical Products, Inc. Assembly of stylet and catheter
US4655745A (en) 1985-07-29 1987-04-07 Corbett Joseph E Ventricular catheter
US4767400A (en) 1987-10-27 1988-08-30 Cordis Corporation Porous ventricular catheter
US4961729A (en) 1988-12-13 1990-10-09 Vaillancourt Vincent L Catheter insertion assembly
US4973319A (en) * 1989-05-10 1990-11-27 Therex Corp. Slit valve medical catheter
US5201723A (en) 1991-08-27 1993-04-13 Cordis Corporation Inclined side holes in the distal end of a catheter
US5207684A (en) 1992-04-13 1993-05-04 Neuro Navigational Corporation Sheath for shunt placement for hydrocephalus
US5405316A (en) 1993-11-17 1995-04-11 Magram; Gary Cerebrospinal fluid shunt
US7090672B2 (en) 1995-06-07 2006-08-15 Arthrocare Corporation Method for treating obstructive sleep disorder includes removing tissue from the base of tongue
US6821265B1 (en) 1996-04-10 2004-11-23 Endoscopic Technologies, Inc. Multichannel catheter
US5928181A (en) 1997-11-21 1999-07-27 Advanced International Technologies, Inc. Cardiac bypass catheter system and method of use
JP2002224222A (en) * 2001-01-30 2002-08-13 Johnson & Johnson Kk Wounded part drain catheter
US7037288B2 (en) 2002-01-14 2006-05-02 Codman & Shurtleff, Inc. Anti-block catheter
US7311690B2 (en) 2002-02-25 2007-12-25 Novashunt Ag Implantable fluid management system for the removal of excess fluid
US20030236483A1 (en) 2002-06-25 2003-12-25 Ren David H Dual drainage ocular shunt for glaucoma
WO2004110391A2 (en) 2003-06-16 2004-12-23 Solx, Inc. Shunt for the treatment of glaucoma
US7226441B2 (en) 2003-06-23 2007-06-05 Codman & Shurtleff, Inc. Catheter with block-overriding system
US7094214B2 (en) 2003-06-27 2006-08-22 Codman & Shurtleff, Inc. System and method for clearing an implanted catheter that is connected to a shunt
US8864710B2 (en) * 2010-01-08 2014-10-21 Art, Limited Infusion sleeve with distendable port

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4465481A (en) * 1981-02-26 1984-08-14 Innovative Surgical Products, Inc. Single piece wound drain catheter
US4795439A (en) * 1986-06-06 1989-01-03 Edward Weck Incorporated Spiral multi-lumen catheter
US4863441A (en) * 1987-07-17 1989-09-05 Minnesota Mining And Manufacturing Company Venous return catheter
US4950232A (en) * 1987-08-11 1990-08-21 Surelab Superior Research Laboratories Cerebrospinal fluid shunt system
US5116310A (en) * 1990-07-30 1992-05-26 Helix Medical, Inc. Multiple lumen wound drain with bypass openings
US5360414A (en) * 1992-10-08 1994-11-01 Yarger Richard J Tube for draining body cavities, viscera and wounds
US5531673A (en) * 1995-05-26 1996-07-02 Helenowski; Tomasz K. Ventricular catheter
US5776096A (en) * 1996-06-06 1998-07-07 Hdc Corporation Dual lumen vascular catheter with expanding side portal
US7223263B1 (en) * 1999-06-16 2007-05-29 Medi-Tech Co., Ltd. Catheter
US7959623B2 (en) * 1999-07-19 2011-06-14 I-Flow Corporation Method of fluid delivery and catheters for use with same
US20030135148A1 (en) * 2002-01-14 2003-07-17 Dextradeur Alan J. Multi-catheter insertion device and method
US20050159697A1 (en) * 2002-01-14 2005-07-21 Codman & Shurtleff, Inc. Multi-catheter insertion device and method
US6893424B2 (en) * 2002-07-04 2005-05-17 Semyon Shchervinsky Drain catheters
US6866657B2 (en) * 2002-07-04 2005-03-15 Semyon Shchervinsky Drain catheters
US20050251144A1 (en) * 2004-05-04 2005-11-10 Codman & Shurtleff, Inc. Multiple lumen sensor attachment
US7604658B2 (en) * 2004-05-04 2009-10-20 Codman & Shurtleff, Inc. Multiple lumen sensor attachment
US20090118661A1 (en) * 2007-11-01 2009-05-07 C. R. Bard, Inc. Catheter assembly including triple lumen tip
US20090254062A1 (en) * 2008-04-03 2009-10-08 Mcglothlin Mark W Infusion catheters with slit valves and of simplified construction

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852156B2 (en) 2012-02-08 2014-10-07 Windrose Medical, Llc. Device for implanting medical catheters
US10639461B2 (en) 2013-01-22 2020-05-05 Anuncia, Inc. Systems and methods for shunting fluid
US20210016068A1 (en) * 2013-01-22 2021-01-21 Anuncia, Inc. Systems and methods for shunting fluid
US20160331927A1 (en) * 2014-01-31 2016-11-17 The Regents Of The University Of Colorado, A Body Corporate Ventricular Catheter
US10493249B2 (en) 2014-04-18 2019-12-03 Anuncia, Inc. System and methods for shunting fluid
US10792480B2 (en) 2016-10-13 2020-10-06 Anuncia, Inc. Shunt flushers and related methods
US10518069B2 (en) 2016-10-28 2019-12-31 Integra LifeSciences Switzerland Sarl Implantable valve assembly with extended lifespan
WO2019035020A1 (en) 2017-08-18 2019-02-21 Aljazaeri Ayman Hassan A Drainage catheter with retractable internal drains
US10500331B2 (en) 2017-08-18 2019-12-10 Ayman H. Al-Jazaeri Drainage catheter with retractable internal drains
US10765847B1 (en) 2019-12-10 2020-09-08 Ayman H. Al-Jazaeri Single lumen drainage catheter with extendable and retractable drains
WO2023089344A1 (en) * 2021-11-22 2023-05-25 Buckingham Medical Technologies Ltd. Medical cannulas

Also Published As

Publication number Publication date
AU2016204328A1 (en) 2016-07-14
AU2011226839A1 (en) 2012-04-12
CA2749653C (en) 2019-12-10
CA2749653A1 (en) 2012-03-29
US10232151B2 (en) 2019-03-19
AU2016204328B2 (en) 2018-05-24
EP2436419B1 (en) 2019-05-08
CO6640044A1 (en) 2013-03-22
US20140228734A1 (en) 2014-08-14
JP2012071135A (en) 2012-04-12
EP2436419A1 (en) 2012-04-04

Similar Documents

Publication Publication Date Title
AU2016204328B2 (en) Multi-lumen ventricular drainage catheter
EP1712252B1 (en) Multi-catheter insertion device
US7037288B2 (en) Anti-block catheter
US7226441B2 (en) Catheter with block-overriding system
JP4309649B2 (en) Cerebrospinal fluid shunt device and hydrocephalus treatment method
RU2193901C2 (en) Catheter usable in particular for performing peritoneal dialysis
US9694166B2 (en) Method of draining cerebrospinal fluid
JP2005058775A (en) Trimmable sensing catheter
US20100121250A1 (en) Dual Channel Shunt Device and Method for Ventriculo-Peritoneal Shunting of Bloody Cerebrospinal Fluid
JP4417013B2 (en) Occlusion prevention catheter
US8333728B2 (en) Implantable cerebrospinal fluid flow device and method of controlling flow of cerebrospinal fluid
US7094214B2 (en) System and method for clearing an implanted catheter that is connected to a shunt
EP2666506B1 (en) Catheter curvature braces
JP2006075275A (en) Medical tube and shunt system

Legal Events

Date Code Title Description
AS Assignment

Owner name: CODMAN & SHURTLEFF, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WILSON, STEPHEN;NEUKOM, EMILIE;SIGNING DATES FROM 20101001 TO 20101006;REEL/FRAME:025373/0283

AS Assignment

Owner name: DEPUY SYNTHES PRODUCTS, LLC, MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:HAND INNOVATIONS LLC;REEL/FRAME:030341/0721

Effective date: 20121231

Owner name: DEPUY SPINE, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CODMAN & SHURTLEFF, INC.;REEL/FRAME:030341/0689

Effective date: 20121230

Owner name: HAND INNOVATIONS LLC, FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DEPUY SPINE, LLC;REEL/FRAME:030341/0713

Effective date: 20121230

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: DEPUY SPINE, LLC, MASSACHUSETTS

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 030341 FRAME: 0689. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:CODMAN & SHURTLEFF, INC.;REEL/FRAME:033684/0122

Effective date: 20121230

AS Assignment

Owner name: DEPUY SYNTHES PRODUCTS, INC., MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:DEPUY SYNTHES PRODUCTS, LLC;REEL/FRAME:039562/0520

Effective date: 20141219